PLEURAL MESOTHELIOMAS

Clinical trials for PLEURAL MESOTHELIOMAS explained in plain language.

Never miss a new study

Get alerted when new PLEURAL MESOTHELIOMAS trials appear

Sign up with your email to follow new studies for PLEURAL MESOTHELIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Double immunotherapy plus chemo: a new hope for Tough-to-Treat cancer?

Disease control Not yet recruiting

This trial is testing whether adding a new immunotherapy drug (fianlimab) to an existing treatment (cemiplimab + standard chemotherapy) can better control advanced pleural mesothelioma, a serious cancer often linked to asbestos exposure. It will involve 126 patients who have not …

Matched conditions: PLEURAL MESOTHELIOMAS

Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

PLEURAL MESOTHELIOMAS

Get alerted when new PLEURAL MESOTHELIOMAS trials appear

Double immunotherapy plus chemo: a new hope for Tough-to-Treat cancer?